Circulating EVs for AML minimal residual disease biomarkers detection: PS229

Affiliations

• ¹ Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Portugal; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, Portugal; ICBAS-UP - Institute of Biomedical Sciences Abel Salazar of the University of Porto, Portugal.
• ² Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Portugal; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, Portugal.
• ³ Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Portugal; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, Portugal; FMUP - Faculty of Medicine of the University of Porto, Portugal; HSJ - Hospital de São João, Porto, Portugal.
• ⁴ Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Portugal; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, Portugal; FFUP - Faculty of Pharmacy of the University of Porto, Portugal.